0867.HK - China Medical System Holdings Limited
| Previous Close | 17.660 |
| Open | 17.620 |
| Bid | 17.660 x 0 |
| Ask | 17.680 x 0 |
| Day's Range | 17.600 - 18.000 |
| 52 Week Range | 12.220 - 20.000 |
| Volume | 5,316,500 |
| Avg. Volume | 6,207,367 |
| Market Cap | 43.875B |
| Beta | 1.03 |
| PE Ratio (TTM) | 21.85 |
| EPS (TTM) | 0.807 |
| Earnings Date | Aug 20, 2018 - Aug 24, 2018 |
| Forward Dividend & Yield | 0.35 (1.90%) |
| Ex-Dividend Date | 2018-04-30 |
| 1y Target Est | 20.35 |
- Reuters•last month
BRIEF-China Medical System Says Trading In Shares Will Resume On May 9
May 9 (Reuters) - China Medical System Holdings Ltd : * TRADING IN SHARES OF CO WILL BE RESUMED AT 9:00 A.M. ON MAY 9 Source text for Eikon: Further company coverage:
- Reuters•last month
BRIEF-China Medical System Holdings Trading In Shares Halted
May 7 (Reuters) - China Medical System Holdings Ltd : * TRADING IN SHARES HALTED AT 9:07 A.M. ON MAY 7 Source text for Eikon: Further company coverage:
- Simply Wall St.•2 months ago
At $18.72, Is China Medical System Holdings Limited (HKG:867) A Buy?
China Medical System Holdings Limited (SEHK:867), a pharmaceuticals company based in China, saw a significant share price rise of over 20% in the past couple of months on the SEHK.Read More...
- Simply Wall St.•2 months ago
Top SEHK Growth Stocks To Buy
High-growth stocks that are financially stable are attractive for many reasons. They provide a strong upside to your portfolio, with less likelihood of downside risks compared to less financially robustRead More...
- Reuters•3 months ago
BRIEF-China Medical System Posts FY Profit Attributable Of RMB1.67 Bln
March 19 (Reuters) - China Medical System Holdings Ltd : * FY TURNOVER UP 9.1% TO RMB5,348.8 MILLION * PROPOSED FINAL DIVIDEND OF RMB0.1393 PER SHARE * FY PROFIT ATTRIBUTABLE RMB1,669.9 MILLION VERSUS ...
- Simply Wall St.•3 months ago
Top Growth Stocks To Buy Now
Looking to enhance your portfolio with high-growth, financially-robust stocks, but not sure where you should even begin? Stocks such as Central China Real Estate and China Medical System Holdings areRead More...
- Simply Wall St.•5 months ago
January Growth Opportunities – BBI Life Sciences And More
Stocks that are expected to significantly grow their profitability in the future can add meaningful upside to your portfolio. BBI Life Sciences and YiChang HEC ChangJiang Pharmaceutical are examples ofRead More...
